The commission shall develop an expedited review process to consider requests from managed care organizations and providers to add drugs to the preferred drug list.

Transferred, redesignated and amended from Government Code, Section 531.072(g) by Acts 2025, 89th Leg., R.S., Ch. 204 (H.B. 1620), Sec. 8.049(b), eff. September 1, 2025.

Added by Acts 2023, 88th Leg., R.S., Ch. 739 (H.B. 3286), Sec. 3, eff. September 1, 2023.